Copyright
©The Author(s) 2021.
World J Clin Oncol. Jul 24, 2021; 12(7): 544-556
Published online Jul 24, 2021. doi: 10.5306/wjco.v12.i7.544
Published online Jul 24, 2021. doi: 10.5306/wjco.v12.i7.544
Figure 1 Examples of BRCA1/2 open-reading frame restoration in BRCA1/2-mutated tumors during systemic therapy.
A: Secondary 1-bp deletion occurring downstream to the germline mutation (BRCA1 c.5266dupC; described in[22]); B: Secondary 4-bp deletion located upstream to the germline mutation (BRCA1 c.3770_3771delAG; an example from[23]); C: Secondary in-frame deletion/insertion excising the mutation-containing gene fragment (BRCA2 c.5946delT; an example from[24]). ORF: Open-reading frame.
- Citation: Imyanitov E, Sokolenko A. Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors. World J Clin Oncol 2021; 12(7): 544-556
- URL: https://www.wjgnet.com/2218-4333/full/v12/i7/544.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i7.544